The Changing Burden of Infectious Disease in Europe-Reference-Cited by-同舟云学术

The Changing Burden of Infectious Disease in Europe

Published:2011-10-05 Issue:103 Volume:3 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Fears Robin¹,van der Meer Jos W. M.²,ter Meulen Volker³

Affiliation:

1. Biosciences Programme Secretariat, European Academies Science Advisory Council, German Academy of Sciences Leopoldina, D-06019 Halle (Saale), Germany.

2. Department of General Internal Medicine, Radboud University Nijmegen Medical Centre and Royal Netherlands Academy of Arts and Sciences, Amsterdam, Netherlands.

3. German Academy of Sciences Leopoldina, D-06019 Halle (Saale), Germany.

Abstract

Opportunities and challenges are described for improving disease surveillance and health care innovation to tackle the growing threats of infection.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference40 articles.

1. Jakab Z. Why a burden of disease study? Euro Surveill. 12 E1–E2 (2007).http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=750

2. Translational Medicine Policy Issues in Infectious Disease

3. EASAC European health and innovation policy for infectious diseases: The view from EASAC; available at http://www.easac.eu (2011).

4. The added value of a European Union tuberculosis reference laboratory network – analysis of the national reference laboratory activities

5. Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Stable Quaternized Chitosan-Black Phosphorus Nanocomposite for Synergetic Disinfection of Antibiotic-Resistant Pathogens;ACS Applied Bio Materials;2021-05-17

2. Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance;Frontiers in Medicine;2018-02-02

3. All-in-one NIR-activated nanoplatforms for enhanced bacterial biofilm eradication;Nanoscale;2018

4. One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model;Biomaterials;2016-04

5. European Academies Advise on Gain-of-Function Studies in Influenza Virus Research;Journal of Virology;2016-03